Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_4

25%

Ph phase_2

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

completed375%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_2

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

NCT07071038

completed

Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites

NCT04301661

completednot_applicable

"Switch Either Near Suppression Or THOusand"

NCT03088241

completedphase_4

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

NCT00338949

Clinical Trials (4)

Showing 4 of 4 trials

NCT07071038Phase 2

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Recruiting

NCT04301661

Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites

Completed

NCT03088241Not Applicable

"Switch Either Near Suppression Or THOusand"

Completed

NCT00338949Phase 4

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4